
Accelerating the impact of science for a better future with @Parkwalk_VC - @nanopore @FLFusion @FeaturespaceLtd #backinginnovation🧬🧪🔬🔭
UK, USA, Australia, NZ
Joined July 2011
- Tweets3.3K
- Following2.6K
- Followers5.9K
- Likes2.5K
🤖 IP Group plc has further invested in Australian AI lab i14 as part of its A$9m funding round.
At a time when compute is the AI industry’s single biggest constraint, i14 is developing new AI architectures inspired by how the human brain handles memory, designed to significantly reduce the compute and energy required to train and run AI models.
A spin-out from the University of Melbourne, i14 has been backed by IP Group Australia from its early days.
Eeshan Kulkarni, Principal at IP Group Australia said: "IP Group is proud to have backed i14 from its first days. At a time when compute is the industry's single biggest constraint, i14's ability to extract many times more intelligence from the same GPUs sets it apart on the global stage."
🔗Link to release in comments
34
🔭 Visionary ventures start here | IP Group Annual Investment Conference 2026
A few more moments from our Annual Investment Conference 2026.
Bringing together entrepreneurs, investors and leaders from across the UK innovation ecosystem, the morning was a reminder of the extraordinary strength of UK science and technology, and the opportunity we have to turn that strength into globally significant companies.
From AI and quantum to life sciences, cleantech and national resilience, one theme came through clearly: breakthrough innovation needs long-term capital, expertise and ambition to scale.
Thank you again to everyone who joined us, shared their perspectives and helped make the morning such a success. 👏
📸 Here are a few more highlights from the day.
#VisionaryVentures #UKInnovation #DeepTech #LifeSciences #Cleantech #Healthtech #AI #ScienceAndTechnology #ScaleUp #UKGrowth #LongTermCapital #BackingInnovation
AccelerComm, adsilico Limited, Audioscenic, Evolito Ltd, Fortify Solutions | Financial Crime Prevention, Genomics, Hynt, Intrinsic, Lumai, Marley Health, Matter Machine, Mind Foundry, Moa Technology, Nyobolt, Oxa, OXCCU TECH LTD, Paragraf, Quantum Motion, Quantum Dice, Oxford Science Enterprises, Northern Gritstone, SETsquared Partnership.
2
184
⚡ Exciting progress for portfolio company @FLFusion, which has partnered with STFC’s Central Laser Facility to advance its FLARE approach to fusion energy.
The collaboration combines First Light’s innovative fusion technology with CLF’s world-leading laser expertise, helping to accelerate the next phase of FLARE’s development towards low-cost, high-gain fusion.
🔗 Link to full release in comments
1
1
161
📬 The November edition of the IP Group newsletter is now live!
This month, we’re sharing the latest news from across the Group and our portfolio, including:
📈 Aberdeen Investments appointing IP Group to manage a UK venture growth portfolio within the CG Scottish Widows Growth LTAF
💡 Highlights from IP Group’s Annual Investment Conference 2026
🚚 DP World becoming the first strategic partner of Oxa’s SHIFFT logistics venture
💻 Lumai taking a major step forward in optical computing
🔬 IP Group and @Parkwalk_VC being confirmed as the UK’s most active investors in spinouts in Beauhurst’s 2026 Equity Investment into Spinouts Report
Plus, more news and updates from across our portfolio.
🔗 Link to newsletter in comments
1
2
220
🔬 Today is World Science Day
For 25 years, IP Group plc and @Parkwalk_VC have backed the scientists, founders and entrepreneurs turning breakthrough research into businesses that can make a real difference.
From new approaches to healthcare and cleaner energy, to the technologies reshaping computing, communications and industry, science sits at the heart of many of the solutions to the world’s biggest challenges.
But translating brilliant science from the lab into real-world impact takes more than a good idea. It takes ambition, expertise, patient capital and long-term support.
Across IP Group and Parkwalk, we’re proud to play our part in helping exceptional science fulfil its potential. 🌍🧬⚛️
#WorldScienceDay
📅 🎤 Just one week to go until MelloLondon!
Finance Director Chris Glasson will be presenting on how we’re backing some of the UK’s most exciting science and technology businesses, followed by a Q&A with attendees.
We hope to see you there.
🎟️ lnkd.in/e6fGqD22
hashtag#MelloLondon Mello Events
4
161
In case you missed our latest insight on new investment into Matter Machine Technologies (MMT)… 🌍
We take a closer look at why we’re backing the University of Liverpool spinout, which is combining AI with world-leading materials science to accelerate the discovery of new materials for applications spanning batteries, clean energy and computing.
🔗 Read more: lnkd.in/da5-dnWX
This week we announced a new partnership with Scottish Widows and Aberdeen Investments that will channel long-term pension capital into some of the UK's most innovative, high-growth businesses.
It's been great to see the Government highlight the importance of the announcement and the growing momentum behind unlocking UK pension capital for the businesses that will drive future growth.
Lucy Rigby KC MP, Economic Secretary to the Treasury and City Minister, described more patient capital flowing to high-growth UK businesses, alongside improved retirement outcomes for savers, as a "win/win for our economy".
Pensions Minister @TorstenBell MP also pointed to the new investment from Scottish Widows through our partnership as "exactly the kind of progress we need to build on."
We couldn't agree more.
There is real momentum across the industry. The challenge now is to build on it: backing Britain's growing businesses, mobilising more long-term institutional capital and delivering better outcomes for pension savers. 🚀
Oxford Quantum Circuits (OQC), Quantum Motion, Nyobolt and Genomics.
👉 Read the full announcement in the comments 👇
#UKInnovation #VentureCapital #Pensions #ScienceAndTechnology #PrivateMarkets
1
179
It’s been an exciting week for portfolio company @IksudaT, which has announced encouraging clinical data from two of its antibody drug conjugate (ADC) programmes.
🩸 IKS03 has shown promising early anti-tumour activity in patients with advanced B-cell lymphoma, including patients previously treated with CAR-T therapy.
🎗️ IKS014 has demonstrated promising activity across HER2-expressing solid tumours, including in breast cancer patients previously treated with Enhertu (T-DXd).
Both programmes also demonstrated encouraging and manageable safety profiles in these early-stage studies.
Congratulations to the Iksuda Therapeutics team👏
Read the full press releases: lnkd.in/dbY9UMQD
Great to see further momentum behind unlocking UK pension capital for innovation and growth. Proud that IP Group is playing a part in turning that ambition into action.🚀
Last week’s Mansion House Accord update showed progress in getting pensions capital → private markets.
More progress on Monday: Scottish Widows announced new investments into innovative UK biz via its partnership w Aberdeen Investments and IP Group.
ipgroupplc.com/news-and-even…
2
232
✨ Visionary ventures start here | IP Group Annual Investment Conference 2026
Today, we’re bringing together entrepreneurs, investors and leaders from across the UK innovation ecosystem for the IP Group Annual Investment Conference 2026.
🌐Against a backdrop of rapid technological change and growing global competition, we’re exploring some of the big questions shaping the future of UK innovation:
💷 How can we mobilise more long-term capital behind high-growth companies?
🚀 What will it take to scale Britain’s next generation of globally significant businesses?
🔬 How can we build on the strength of our universities and science base?
🌍 What role will science and technology play in national security and resilience?
🤖 How can the UK build and benefit from the AI revolution?
We’re delighted to be joined by an outstanding line-up of speakers, including Will Hutton and Sir Jeremy Fleming alongside our Chair Michael Queen and our CEO Greg Smith with panels hosted by Anne Dobrée from @Parkwalk_VC, our EIS fund management business, Mark Reilly and Dr Lee Thornton and a fireside chat hosted by David Townsend.
💡 And throughout the morning, our portfolio showcase is bringing some of that innovation to life, with companies working across AI, quantum computing, semiconductors, autonomy, genomics, cleantech, aerospace, defence and next-generation computing.
From breakthrough science to global scale, today is about the ideas, capital and connections needed to build the next generation of globally significant companies.
🙏 A huge thank you to everyone for sharing insights, sparking ideas and building connections that will shape the future.
🔭 Visionary ventures start here.
#VisionaryVentures #UKInnovation #DeepTech #LifeSciences #Cleantech #Healthtech #AI #ScienceAndTechnology #ScaleUp #UKGrowth #LongTermCapital #BackingInnovation
AccelerComm, adsilico Limited, Audioscenic, Evolito Ltd, Fortify Solutions | Financial Crime Prevention, Genomics, Hynt, Intrinsic, Lumai, Marley Health, Matter Machine, Mind Foundry, Moa Technology, Nyobolt, Oxa, OXCCU TECH LTD, Paragraf, Quantum Motion, Quantum Dice, Oxford Science Enterprises, Northern Gritstone, SETsquared Partnership.
1
187
💡 Major step forward in optical computing for portfolio company Lumai.
The UK's Advanced Research + Invention Agency (ARIA) has selected portfolio company Lumai as the first optical inference platform for its Scaling Inference Lab, where an eight-node Lumai Iris™ system will run production-scale AI models in a commercial data centre.
Crucially, this takes Lumai’s technology beyond its own lab, allowing independent teams to test its performance on real workloads.
Lumai uses light to carry out some of the most compute-intensive parts of AI inference, with its roadmap targeting up to 90% lower power consumption and around one-tenth the total cost of ownership of conventional GPU architectures.
An exciting step towards proving the potential of optical computing for faster, more energy-efficient AI infrastructure. ⚡
👉 Read the announcement in the comments below👇
1
4
220
🎥 Why does unlocking UK pension capital for innovation matter?
Our CEO Greg Smith spoke to @proactive_x about IP Group’s new mandate with Aberdeen Investments and Scottish Widows, and the opportunity to connect long-term pension savings with some of the UK’s most exciting science and technology companies.
Greg discusses the need for greater growth capital to help UK businesses commercialise and scale, the first investments across quantum computing, advanced batteries and AI-enabled healthcare, and why we believe this could be the beginning of a much bigger opportunity. 🚀
Watch the interview below 👇
IP Group, Aberdeen and Scottish Widows unlock pension capital for UK innovation @IPGroupplc proactiveinvestors.com/compa… #Growth #Technology #IP #ScottishWidows #AberdeenInvestments #IPO
154
🚀 Unlocking pension capital for UK innovation
We’re delighted to have been appointed by Aberdeen Investments to manage a UK venture growth portfolio within the CG Scottish Widows Growth LTAF.
The partnership will connect long-term pension capital with some of the UK’s most exciting science and technology companies, helping address a critical constraint on the UK innovation economy: access to meaningful growth capital for businesses ready to commercialise and scale.
⚛️🔋🧬The first investments are expected to span quantum computing, advanced battery technology and AI-enabled healthcare, including Oxford Quantum Circuits, Quantum Motion, Nyobolt and Genomics Limited.
For IP Group, this is an important example of how long-term institutional capital can support world-class British innovation and help the next generation of technology leaders move from scientific leadership to commercial scale.
And we believe this is just the beginning. 🚀
👉 Read the full announcement in the comments 👇
#UKInnovation #VentureCapital #Pensions #ScienceAndTechnology #PrivateMarkets
🌍 Cleantech remains an important area of focus for IP Group, particularly where breakthrough science and technology can help tackle some of the world’s biggest challenges.
🤖🔬 In our latest insight, Arielle Schacter and Ben Murphy, Investment Directors, Cleantech, explain why we invested in Matter Machine, a University of Liverpool spinout combining AI, automation and world-leading materials science to push the boundaries of materials discovery.
🚀 Arielle and Ben look at the team, science and differentiated approach behind Matter Machine, and why we believe it has the foundations to make a real impact.
Read why we invested. Link in the comments 👇
Gordon Sanghera, Northern Gritstone, University of Liverpool Enterprise Fund, Norrsken Evolve, LYVA Labs & the Northern Universities Venture Fund managed by @Parkwalk_VC, our EIS fund management business.
Check out the new Matter Machine website at: matter-machine.com/
1
2
150
















